Amp Capital Investors LTD Exact Sciences Corp Transaction History

Amp Capital Investors LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$72.5 - $100.68 $2.82 Million - $3.92 Million	-38,887 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$90.24 - $124.05 $282,270 - $388,028	-3,128 Reduced 7.44%	38,887 $3.71 Million
Q2 2021 Aug 16, 2021	BUY	$93.66 - $139.27 $28,004 - $41,641	299 Added 0.72%	42,015 $5.24 Million
Q1 2021 May 17, 2021	BUY	$116.57 - $155.01 $425,014 - $565,166	3,646 Added 9.58%	41,716 $5.47 Million
Q4 2020 Feb 12, 2021	SELL	$99.61 - $142.12 $27,093 - $38,656	-272 Reduced 0.71%	38,070 $5.15 Million
Q3 2020 Nov 12, 2020	BUY	$72.92 - $102.01 $58,336 - $81,608	800 Added 2.13%	38,342 $3.91 Million
Q2 2020 Aug 14, 2020	BUY	$55.75 - $92.75 $1,505 - $2,504	27 Added 0.07%	37,542 $3.23 Million
Q1 2020 May 13, 2020	SELL	$37.9 - $104.44 $79,286 - $218,488	-2,092 Reduced 5.28%	37,515 $2.19 Million
Q4 2019 Feb 13, 2020	SELL	$77.66 - $99.74 $1.18 Million - $1.51 Million	-15,151 Reduced 27.67%	39,607 $3.64 Million
Q3 2019 Nov 13, 2019	BUY	$90.37 - $122.49 $1.82 Million - $2.47 Million	20,133 Added 58.15%	54,758 $5.04 Million
Q2 2019 Aug 14, 2019	BUY	$89.51 - $118.04 $3.1 Million - $4.09 Million	34,625 New	34,625 $3.98 Million

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.3B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Amp Capital Investors LTD, based on Form 13F filings with the SEC.

Stay updated on Amp Capital Investors LTD with notifications on news.